Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Optimal Transition Program

NCT04263233 is registered in ClinicalTrials.gov with Satellite Healthcare as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04263233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Optimal Transition Program
Lead sponsor
Satellite Healthcare
Phase
Observational
Overall status
Unknown status
Start date
January 29, 2020
Completion date
December 31, 2022
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esrd, hemodialysis